PLASMANATE

This brand name is authorized in United States. It is also authorized in Hong Kong SAR China, Singapore.

Active ingredients

The drug PLASMANATE contains one active pharmaceutical ingredient (API):

1	Albumin UNII ZIF514RVZR - ALBUMIN HUMAN
	Human albumin accounts quantitatively for more than half of the total protein in the plasma and represents about 10% of the protein synthesis activity of the liver. The most important physiological functions of albumin results from its contribution to oncotic pressure of the blood and transport function. Albumin stabilises circulating blood volume and is a carrier of hormones, enzymes, medicinal products and toxins.
	Read more about Albumin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PLASMANATE Solution for infusion	MPI, US: SPL/Old	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B05AA02	Other plasma protein fractions	B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05A Blood and related products → B05AA Blood substitutes and plasma protein fractions
Discover more medicines within B05AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
HK	Department of Health Drug Office	06007
SG	Health Sciences Authority	01064P
US	FDA, National Drug Code	13533-613